$98.82
Price
$6.3B
Market Cap
—
P/E Ratio
-227.6
Forward P/E
$-2.05
EPS (TTM)
—
Dividend Yield
$567M
Cash
$10M
Total Debt
64M
Shares Out
$41.28
$107.84
52-Week Range
Institutional Ownership of PROTAGONIST THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
| No funds currently hold this stock. | |||||
Trading Activity for PROTAGONIST THERAPEUTICS INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2025-Q3 | |||||
| BUY | +27.0% | 20.3K | $1M | $56.21 | |
| 2025-Q2 | |||||
| BUY | NEW | 16.0K | $884265 | $45.85 | |
Insider Trading for PROTAGONIST THERAPEUTICS INC
6 Months Insider Sentiment
Buy $0
Sell $230K
0
Buys
1
Sells
-230K
Net
9
Grants
Largest
$230K
MD
$60K
Selick
| Date |
Insider
Click to search
|
Role
Click to search
|
Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Jan 09, 2026 | Harold E Selick | Director | EXERCISE | 14.3K | $4.21 | $60K |
| Jan 02, 2026 | Arturo Molina MD | Chief Medical Officer | GRANT | 25.6K | — | — |
| Jan 02, 2026 | Asif Ali | Chief Financial Officer | GRANT | 25.6K | — | — |
| Jan 02, 2026 | Bryan Giraudo | Director | GRANT | 2.7K | — | — |
| Jan 02, 2026 | Harold E Selick | Director | GRANT | 2.7K | — | — |
| Jan 02, 2026 | Lewis T Williams | Director | GRANT | 2.7K | — | — |
| Jan 02, 2026 | William D. Waddill | Director | GRANT | 2.7K | — | — |
| Jan 02, 2026 | PATEL DINESH V PH D | President and CEO | GRANT | 95.4K | — | — |
| Jan 02, 2026 | Sarah A O'Dowd | Director | GRANT | 2.7K | — | — |
| Nov 21, 2025 | PATEL DINESH V PH D | President and CEO | GRANT | 440 | — | — |
| Nov 17, 2025 | Arturo Molina MD | Chief Medical Officer | SELL | 2.7K | $84.77 | $230K |